Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

NCT07476027 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

T Lymphoblastic Lymphoma
T Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: CD7 CAR-T cell intravenous infusion

Sponsor

Institute of Hematology & Blood Diseases Hospital, China